Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Pharmacol ; 406(1): 69-74, 2000 Oct 06.
Artigo em Inglês | MEDLINE | ID: mdl-11011035

RESUMO

We investigated the role of endogenous endothelins in catecholamine secretion in response to transmural electrical stimulation in the retrogradely perfused rat adrenal gland. (R)2-[(R)-2-[(S)-2-[[1-(hexahydro-1H-azepinyl)]carbonyl]amino-4-++ +methy l-pentanoyl]amino-3-[3-(1-methyl-1H-indoyl)]propionyl]amino-3-(2-+ ++pyridyl) propionic acid (FR139317; 0.03-3 microM), an endothelin ET(A) receptor antagonist, inhibited the electrical stimulation-induced epinephrine and norepinephrine output. Neither N-cis-2, 6-dimethylpiperidinocarbonyl-L-gamma-methylleucyl-D-1- methoxycarbonyl tryptophanyl-D-norleucine (BQ-788; 0.03-3 microM), an endothelin ET(B) receptor antagonist, nor phosphoramidon (1-100 mM), an endothelin-converting enzyme inhibitor, affected the catecholamine output responses. However, the inhibition by FR139317 of the catecholamine output responses was abolished by pretreatment with phosphoramidon (100 mM) or BQ-788 (3 microM). These results indicate that activation of endothelin ET(B) receptors by endogenous endothelins inhibits the catecholamine output responses under the condition in which endothelin ET(A) receptors are blocked. Exogenous endothelin-1 (1-100 nM) did not affect the catecholamine output responses, but it inhibited the responses under treatment with phosphoramidon and FR139317. Activation of endothelin ET(A) receptors may interfere with the endothelin ET(B) receptor-mediated inhibitory action on the neuronally evoked secretion of adrenal catecholamines.


Assuntos
Glândulas Suprarrenais/efeitos dos fármacos , Catecolaminas/metabolismo , Endotelinas/fisiologia , Glândulas Suprarrenais/metabolismo , Animais , Azepinas/farmacologia , Relação Dose-Resposta a Droga , Estimulação Elétrica , Endotelina-1/farmacologia , Epinefrina/metabolismo , Glicopeptídeos/farmacologia , Técnicas In Vitro , Indóis/farmacologia , Masculino , Norepinefrina/metabolismo , Oligopeptídeos/farmacologia , Piperidinas/farmacologia , Ratos , Ratos Wistar
2.
J Physiol ; 520 Pt 2: 503-12, 1999 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-10523418

RESUMO

1. We elucidated the contribution of voltage-dependent Ca2+ channels to cholinergic control of catecholamine secretion in the isolated perfused rat adrenal gland. 2. Nifedipine (0.3-3 microM) inhibited increases in noradrenaline output induced by transmural electrical stimulation (1-10 Hz) and acetylcholine (6-200 microM), whereas it only slightly inhibited the adrenaline output responses. Nifedipine also inhibited the catecholamine output response induced by 1, 1-dimethyl-4-phenyl-piperazinium (DMPP; 5-40 microM) but not by methacholine (10-300 microM). 3. omega-Conotoxin MVIIC (10-1000 nM) inhibited the catecholamine output responses induced by electrical stimulation but not by acetylcholine, DMPP and methacholine. 4. omega-Conotoxin GVIA (50-500 nM) had no inhibitory effect on the catecholamine output responses. 5. These results suggest that L-type Ca2+ channels are responsible for adrenal catecholamine secretion mediated by nicotinic receptors but not by muscarinic receptors, and that their contribution to noradrenaline secretion may be greater than that to adrenaline secretion. P/Q-type Ca2+ channels may control the secretion at a presynaptic site.


Assuntos
Glândulas Suprarrenais/metabolismo , Canais de Cálcio Tipo L/metabolismo , Catecolaminas/metabolismo , Acetilcolina/farmacologia , Animais , Atropina/farmacologia , Iodeto de Dimetilfenilpiperazina/farmacologia , Estimulação Elétrica , Hexametônio/farmacologia , Masculino , Cloreto de Metacolina/farmacologia , Nifedipino/farmacologia , Norepinefrina/metabolismo , Ratos , Ratos Wistar , Transmissão Sináptica , ômega-Conotoxinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...